SCHEMBL4127646

SCHEMBL4127646

CCOc1cc2ccccc2cc1C=C1SC(Nc2ccc(CC(N)=O)cc2)=NC1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.40
DAPK3 O43293 1/20 0.40
PRKD3 O94806 1/20 0.40
PIM1 P11309 1/20 0.40
MAPK8 P45983 1/20 0.40
CSNK1A1 P48729 1/20 0.40
CDK8 P49336 1/20 0.40
CLK2 P49760 1/20 0.40
CDK9 P50750 1/20 0.40
CDK5 Q00535 1/20 0.40
DYRK1A Q13627 1/20 0.40
LRRK2 Q5S007 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
DYRK1B Q9Y463 1/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
TDP1 Q9NUW8 1/20 0.40
PTP4A3 O75365 3/20 0.38
POLB P06746 1/20 0.38
PABPC1 P11940 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4127749 0.86 KMT2A (0.46) MEN1KMT2ATDP1PTP4A3POLB
SCHEMBL4127754 0.86 KMT2A (0.46) MEN1KMT2ATDP1PTP4A3POLB
Acetic Acid SCHEMBL4635218 0.85 CHEK1 (0.39) CHEK1DAPK3PRKD3PIM1MAPK8
Acetic Acid SCHEMBL4635217 0.85 CHEK1 (0.39) CHEK1DAPK3PRKD3PIM1MAPK8
SCHEMBL4125733 0.83 PTP4A3 (0.50) MEN1KMT2ATDP1PTP4A3POLB
SCHEMBL4125736 0.83 PTP4A3 (0.50) MEN1KMT2ATDP1PTP4A3POLB
SCHEMBL4139338 0.81 KMT2A (0.37) MEN1KMT2AGAAMAPTRXFP1
SCHEMBL4139335 0.81 KMT2A (0.37) MEN1KMT2AGAAMAPTRXFP1
SCHEMBL4128924 0.80 S1PR1 (0.43) MEN1KMT2ATDP1PTP4A3PDE4B
SCHEMBL4128926 0.80 S1PR1 (0.43) MEN1KMT2ATDP1PTP4A3PDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors TORRENT PHARMACEUTICALS LIMITED (IN) 2009-04-02 US claimed
EP-1934192-A1 THIAZOLINONES AND OXAZOLINONES AND THEIR USE AS PTP1B INHIBITORS Torrent Pharmaceuticals Ltd (IN) 2008-06-25 EP claimed
WO-2007032028-A1 THIAZOLINONES AND OXAZOLINONES AND THEIR USE AS PTP1B INHIBITORS TORRENT PHARMACEUTICALS LTD. (IN) 2007-03-22 WO claimed
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors TORRENT PHARMACEUTICALS LIMITED (IN) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors PTPRF, PTPA, PTPRJ CHEK1 3804/4885DAPK3 579/4885PRKD3 2359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.